EGFR and glioblastoma: While previous literature has advocated the independent prognostic significance of PTEN loss in glioblastoma [1], [8], [29], [31], other studies have demonstrated the importance of EGFR amplification as well as other methods of Akt pathway activation in tumorigenesis [1], [40]–[42].